Clinical Trials
As an infrastructure at the German Center for Infection Research (DZIF), the Clinical Trial Unit tracks DZIF's study activities in the “Healex Site Management System (SMS)”. Studies are sorted by indication and are continuously updated.
The study register has recently been expanded to include the category “COVID-19”. For the first time, not only DZIF study activities are presented here: In order to provide a comprehensive overview in the current pandemic situation of planned and already active COVID-19 studies in Germany, the Clinical Trial Unit is cooperating with researchers from various German Centers for Health Research and other networks.
For researchers: If your study is not yet included in our portal, please contact the project management of the Clinical Trial Unit.
EUROSIDA
- Overall study
- Study Sites (1)
Acronym | ISRCTN | EudraCT | NCT (clinicaltrials.gov) | DRKS |
---|---|---|---|---|
EUROSIDA Kohorte
Status: Active
Purpose / Objectives
Primary Outcome
database
Secondary Outcomes
na
Diagnosis
- HIV-1
- Infectiology/HIV and AIDS
HIV
Target population
Stage
HIV
Age
18-99
Inclusion criteria
NA
Exclusion criteria
na
Study design
- Multicenter
- Retrospective
Intervention
na
Documents (password protected)
Responsibilities in overall study
Sponsor
CHIP Kopenhagen
- Tel. +45 35 45 5757
- Fax +45 35 45 5758
(National) Coordinating Investigator
Univ.-Prof. Dr. med. Gerd Fätkenheuer